Review



cd133 cells  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Miltenyi Biotec cd133 cells
    Cd133 Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 109 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+cells/CD133+MicroBead+Kit%2C+human+-+lyophilized/pmc12860264-131-7-14
    Average 95 stars, based on 109 article reviews
    cd133 cells - by Bioz Stars, 2026-08
    95/100 stars

    Images



    Similar Products

    95
    Miltenyi Biotec cd133 cells
    Cd133 Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+cells/CD133+MicroBead+Kit%2C+human+-+lyophilized/pmc12860264-131-7-14
    Average 95 stars, based on 1 article reviews
    cd133 cells - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd133 cell populations
    Cd133 Cell Populations, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+cells/Prominin-1+Antibody%2C+anti-mouse/pm40925433-58-0-13
    Average 96 stars, based on 1 article reviews
    cd133 cell populations - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec magnetic assisted cell sorting technology
    Magnetic Assisted Cell Sorting Technology, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+cells/CD133+MicroBead+Kit+-+Tumor+Tissue%2C+human/pmc12221726-82-14-19
    Average 93 stars, based on 1 article reviews
    magnetic assisted cell sorting technology - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec cd133 spheroid cells
    Knockdown of YWHAB promotes stemness and chemoresistance in OCPM. (A) The diameter and the number of the spheroids derived from YWHAB-knockdown and control primary CR OCPM cells were tested (one-way ANOVA; n = 3 biological replicates). (B) The mRNA level of <t>CD133</t> (left) and the ALDH activity (right) in indicated cells were analyzed by quantitative PCR and ALDH activity assay, respectively (one-way ANOVA; n = 3 biological replicates). (C) The proportions of CD133 + ALDH + cells in indicated cells were analyzed by flow cytometry (one-way ANOVA; n = 3 biological replicates). (D) The frequencies of in vitro sphere-forming cells (left) and in vivo tumor-initiating cells (right) in indicated cells were analyzed by limiting dilution assay (extreme limiting dilution analyses, for in vitro assay, n = 50 biological replicates per group, three groups (1, 5, and 10 cells per well); for in vivo assay, n = 10 biological replicates per group, three groups (8, 40, and 200 cells per mice)). (E) The IC 50 values of cisplatin in indicated primary CR OCPM cells were tested ( n = 3 biological replicates). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Cd133 Spheroid Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+cells/CD133+MicroBead+Kit+-+Tumor+Tissue%2C+human/pmc12221726-82-7-19
    Average 93 stars, based on 1 article reviews
    cd133 spheroid cells - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    90
    Stamm GmbH autologous cd133 + marrow cells
    Knockdown of YWHAB promotes stemness and chemoresistance in OCPM. (A) The diameter and the number of the spheroids derived from YWHAB-knockdown and control primary CR OCPM cells were tested (one-way ANOVA; n = 3 biological replicates). (B) The mRNA level of <t>CD133</t> (left) and the ALDH activity (right) in indicated cells were analyzed by quantitative PCR and ALDH activity assay, respectively (one-way ANOVA; n = 3 biological replicates). (C) The proportions of CD133 + ALDH + cells in indicated cells were analyzed by flow cytometry (one-way ANOVA; n = 3 biological replicates). (D) The frequencies of in vitro sphere-forming cells (left) and in vivo tumor-initiating cells (right) in indicated cells were analyzed by limiting dilution assay (extreme limiting dilution analyses, for in vitro assay, n = 50 biological replicates per group, three groups (1, 5, and 10 cells per well); for in vivo assay, n = 10 biological replicates per group, three groups (8, 40, and 200 cells per mice)). (E) The IC 50 values of cisplatin in indicated primary CR OCPM cells were tested ( n = 3 biological replicates). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Autologous Cd133 + Marrow Cells, supplied by Stamm GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd133+cells/cd133++bone+marrow+cells/pmc12209992-11-6-0
    Average 90 stars, based on 1 article reviews
    autologous cd133 + marrow cells - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    Image Search Results


    Knockdown of YWHAB promotes stemness and chemoresistance in OCPM. (A) The diameter and the number of the spheroids derived from YWHAB-knockdown and control primary CR OCPM cells were tested (one-way ANOVA; n = 3 biological replicates). (B) The mRNA level of CD133 (left) and the ALDH activity (right) in indicated cells were analyzed by quantitative PCR and ALDH activity assay, respectively (one-way ANOVA; n = 3 biological replicates). (C) The proportions of CD133 + ALDH + cells in indicated cells were analyzed by flow cytometry (one-way ANOVA; n = 3 biological replicates). (D) The frequencies of in vitro sphere-forming cells (left) and in vivo tumor-initiating cells (right) in indicated cells were analyzed by limiting dilution assay (extreme limiting dilution analyses, for in vitro assay, n = 50 biological replicates per group, three groups (1, 5, and 10 cells per well); for in vivo assay, n = 10 biological replicates per group, three groups (8, 40, and 200 cells per mice)). (E) The IC 50 values of cisplatin in indicated primary CR OCPM cells were tested ( n = 3 biological replicates). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: Genes & Diseases

    Article Title: Restriction of YWHAB-mediated YAP cytoplasmic retention is a novel mechanism underlying stemness maintenance and chemoresistance in ovarian cancer peritoneal metastasis

    doi: 10.1016/j.gendis.2025.101519

    Figure Lengend Snippet: Knockdown of YWHAB promotes stemness and chemoresistance in OCPM. (A) The diameter and the number of the spheroids derived from YWHAB-knockdown and control primary CR OCPM cells were tested (one-way ANOVA; n = 3 biological replicates). (B) The mRNA level of CD133 (left) and the ALDH activity (right) in indicated cells were analyzed by quantitative PCR and ALDH activity assay, respectively (one-way ANOVA; n = 3 biological replicates). (C) The proportions of CD133 + ALDH + cells in indicated cells were analyzed by flow cytometry (one-way ANOVA; n = 3 biological replicates). (D) The frequencies of in vitro sphere-forming cells (left) and in vivo tumor-initiating cells (right) in indicated cells were analyzed by limiting dilution assay (extreme limiting dilution analyses, for in vitro assay, n = 50 biological replicates per group, three groups (1, 5, and 10 cells per well); for in vivo assay, n = 10 biological replicates per group, three groups (8, 40, and 200 cells per mice)). (E) The IC 50 values of cisplatin in indicated primary CR OCPM cells were tested ( n = 3 biological replicates). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: After the spheroid cells reached 60% confluence, CD133 + spheroid cells were separated by magnetic-assisted cell sorting technology (#130-100-857, Miltenyi Biotech) according to the manual.

    Techniques: Knockdown, Derivative Assay, Control, Activity Assay, Real-time Polymerase Chain Reaction, Flow Cytometry, In Vitro, In Vivo, Limiting Dilution Assay

    The effects of YWHAB knockdown on the stemness were significantly abolished in YAP5SA-overexpressing cells. (A) The diameter and the number of the spheroids derived from YAP5SA-overexpressing and empty-vector control cells transfected with shRNAs against YWHAB and control shRNAs were measured (one-way ANOVA; n = 3 biological replicates). (B) The mRNA level of CD133 (left) and the ALDH activity (right) in indicated cells were determined by quantitative PCR and ALDH activity assay, respectively (one-way ANOVA; n = 3 biological replicates). (C) The proportion of CD133 + ALDH + cells in indicated cells was analyzed by flow cytometry (one-way ANOVA; n = 3 biological replicates). (D) The frequencies of in vitro sphere-forming cells (left) and in vivo tumor-initiating cells (right) in indicated cells were analyzed by limiting dilution assay (extreme limiting dilution analyses; for in vitro assay, n = 50 biological replicates per group, three groups (1, 5, and 10 cells per well); for in vivo assay, n = 10 biological replicates per group, three groups (8, 40, and 200 cells per mice)). (E) The IC 50 values of cisplatin in indicated cells were tested by cell viability assay ( n = 3 biological replicates). The inhibition rate of 100 uM cisplatin in indicated cells was provided. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: Genes & Diseases

    Article Title: Restriction of YWHAB-mediated YAP cytoplasmic retention is a novel mechanism underlying stemness maintenance and chemoresistance in ovarian cancer peritoneal metastasis

    doi: 10.1016/j.gendis.2025.101519

    Figure Lengend Snippet: The effects of YWHAB knockdown on the stemness were significantly abolished in YAP5SA-overexpressing cells. (A) The diameter and the number of the spheroids derived from YAP5SA-overexpressing and empty-vector control cells transfected with shRNAs against YWHAB and control shRNAs were measured (one-way ANOVA; n = 3 biological replicates). (B) The mRNA level of CD133 (left) and the ALDH activity (right) in indicated cells were determined by quantitative PCR and ALDH activity assay, respectively (one-way ANOVA; n = 3 biological replicates). (C) The proportion of CD133 + ALDH + cells in indicated cells was analyzed by flow cytometry (one-way ANOVA; n = 3 biological replicates). (D) The frequencies of in vitro sphere-forming cells (left) and in vivo tumor-initiating cells (right) in indicated cells were analyzed by limiting dilution assay (extreme limiting dilution analyses; for in vitro assay, n = 50 biological replicates per group, three groups (1, 5, and 10 cells per well); for in vivo assay, n = 10 biological replicates per group, three groups (8, 40, and 200 cells per mice)). (E) The IC 50 values of cisplatin in indicated cells were tested by cell viability assay ( n = 3 biological replicates). The inhibition rate of 100 uM cisplatin in indicated cells was provided. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: After the spheroid cells reached 60% confluence, CD133 + spheroid cells were separated by magnetic-assisted cell sorting technology (#130-100-857, Miltenyi Biotech) according to the manual.

    Techniques: Knockdown, Derivative Assay, Plasmid Preparation, Control, Transfection, Activity Assay, Real-time Polymerase Chain Reaction, Flow Cytometry, In Vitro, In Vivo, Limiting Dilution Assay, Viability Assay, Inhibition